Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | ACLY | P53396 | 2/20 | 0.49 |
| ▸ | ACACA | Q13085 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
| ▸ | PTGES | O14684 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10017520 | 0.94 | ACLY (0.47) | MEN1KMT2AACLYACACAMAPT | |
| SCHEMBL10049046 | 0.93 | MEN1 (0.53) | MEN1KMT2AACLYACACAMAPT | |
| SCHEMBL10017464 | 0.91 | MEN1 (0.54) | MEN1KMT2AACLYACACAMAPT | |
| SCHEMBL11994839 | 0.90 | MEN1 (0.52) | MEN1KMT2AACLYACACAMAPT | |
| Gamma Oryzanol SCHEMBL21235210 | 0.90 | MEN1 (0.60) | MEN1KMT2AACLYACACAMAPT | |
| Gamma Oryzanol SCHEMBL23105398 | 0.90 | MEN1 (0.60) | MEN1KMT2AACLYACACAMAPT | |
| Gamma Oryzanol SCHEMBL29357024 | 0.90 | MEN1 (0.60) | MEN1KMT2AACLYACACAMAPT | |
| Gamma Oryzanol SCHEMBL29354302 | 0.90 | MEN1 (0.60) | MEN1KMT2AACLYACACAMAPT | |
| Gamma Oryzanol SCHEMBL718726 | 0.90 | MEN1 (0.60) | MEN1KMT2AACLYACACAMAPT | |
| Gamma Oryzanol SCHEMBL12152368 | 0.90 | MEN1 (0.60) | MEN1KMT2AACLYACACAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9541795-B2 | Liquid crystal display device and method for manufacturing the same | SONY CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-9523889-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-12-20 | — | — | US | disclosed |
| US-9507210-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9470929-B2 | Liquid crystal display unit and method of manufacturing the same | SONY CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-9465244-B2 | Liquid crystal display | SONY CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9366910-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2016-06-14 | — | — | US | disclosed |
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2016-01-14 | — | — | US | disclosed |
| US-9235084-B2 | Liquid crystal display device and manufacturing method thereof | SONY CORPORATION (JP) | 2016-01-12 | — | — | US | disclosed |
| US-9146425-B2 | Liquid crystal display and method of manufacturing the same | SONY CORPORATION (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20150146148-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2015-05-28 | — | — | US | disclosed |
| US-20140071390-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2014-03-13 | — | — | US | disclosed |
| US-20130155360-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130010244-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION | 2013-01-10 | — | — | US | disclosed |
| US-20120218500-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-30 | — | — | US | disclosed |
| US-20120212691-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120212697-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF | SONY CORPORATION (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120026440-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2012-02-02 | — | — | US | disclosed |
| US-20110273652-A1 | LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-11-10 | — | — | US | disclosed |
| US-20110157531-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2011-06-30 | — | — | US | disclosed |
| US-20110134382-A1 | LIQUID CRYSTAL DISPLAY ELEMENT AND LIQUID CRYSTAL DISPLAY DEVICE | SONY CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160011463-A1 | LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME | PYM1, PDCD2L, SDAD1 | MEN1 2607/4885KMT2A 3545/4885ACLY 4858/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.